Correction: Kikuchi, K., et al., Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke. Int. J. Mol. Sci. 2013, 14, 18899–18924

The original version of the paper [1] reports that "This ACTIVE I study was supported by Pfizer" (Page 18905). However, the sponsors of the ACTIVE I study were actually Bristol-Myers Squibb and Sanofi-Aventis rather than Pfizer. [...]

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 15; no. 4; pp. 5410 - 5411
Main Authors Kikuchi, Kiyoshi, Tancharoen, Salunya, Ito, Takashi, Morimoto-Yamashita, Yoko, Miura, Naoki, Kawahara, Ko-ichi, Maruyama, Ikuro, Murai, Yoshinaka, Tanaka, Eiichiro
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 27.03.2014
Molecular Diversity Preservation International (MDPI)
Subjects
n/a
Online AccessGet full text

Cover

More Information
Summary:The original version of the paper [1] reports that "This ACTIVE I study was supported by Pfizer" (Page 18905). However, the sponsors of the ACTIVE I study were actually Bristol-Myers Squibb and Sanofi-Aventis rather than Pfizer. [...]
Bibliography:correction
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms15045410